Positive Trial Data on Evolut TAVR Likely to Support MDT Stock

Medtronic plc (MDT) recently unveiled two-year Small Annuli Randomized to Evolut or SAPIEN (“SMART”) Trial results at the Cardiovascular Research Technologies (“CRT”) 2025 conference in Washington, D.C. SMART trial is the largest international head-to-head comparative trial of transfemoral transcatheter aortic valve replacement ("TAVR"), conducted in patients with aortic stenosis ("AS") and a small aortic annulus. The two-year results highlighted the continued superior performance of the Evolut TAVR valve i ...